| Bioactivity | PPARδ/γ agonist 1 sodium is a chemically unique and brain penetrant dual PPAR delta/gamma agonist. PPARδ/γ agonist 1 sodium can be used for the research of Alzheimer’s disease[1]. |
| In Vivo | PPARδ/γ agonist 1 sodium (1 mg/kg; i.g. once daily for 16 days) restores STZ-mediated impairments of motor function[1]. Animal Model: |
| Name | PPARδ/γ agonist 1 sodium |
| CAS | 1258076-66-2 |
| Formula | C25H26NNaO5 |
| Molar Mass | 443.47 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |
| Reference | [1]. Tong M, et al. T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer's Disease. J Alzheimers Dis. 2016;51(1):123-38. |
PPARδ/γ agonist 1 sodium
CAS: 1258076-66-2 F: C25H26NNaO5 W: 443.47
PPARδ/γ agonist 1 sodium is a chemically unique and brain penetrant dual PPAR delta/gamma agonist. PPARδ/γ agonist 1
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.